| Literature DB >> 34885273 |
Juan Carlos Marín-Payá1, Blanca Díaz-Benito1, Luis Amaro Martins1, Sandra Clara Trujillo1,2, Lourdes Cordón3,4, Senentxu Lanceros-Méndez5,6,7, Gloria Gallego Ferrer1,2, Amparo Sempere3,4,8, José Luis Gómez Ribelles1,2.
Abstract
The development of three-dimensional environments to mimic the in vivo cellular response is a problem in the building of disease models. This study aimed to synthesize and validate three-dimensional support for culturing monoclonal plasma cells (mPCs) as a disease model for multiple myeloma. The three-dimensional environment is a biomimetic microgel formed by alginate microspheres and produced on a microfluidic device whose surface has been functionalized by a layer-by-layer process with components of the bone marrow's extracellular matrix, which will interact with mPC. As a proof of concept, RPMI 8226 cell line cells were cultured in our 3D culture platform. We proved that hyaluronic acid significantly increased cell proliferation and corroborated its role in inducing resistance to dexamethasone. Despite collagen type I having no effect on proliferation, it generated significant resistance to dexamethasone. Additionally, it was evidenced that both biomolecules were unable to induce resistance to bortezomib. These results validate the functionalized microgels as a 3D culture system that emulates the interaction between tumoral cells and the bone marrow extracellular matrix. This 3D environment could be a valuable culture system to test antitumoral drugs efficiency in multiple myeloma.Entities:
Keywords: biocomposites; biopolymers; collagen; hyaluronic acid; microgel; multiple myeloma
Year: 2021 PMID: 34885273 PMCID: PMC8658353 DOI: 10.3390/ma14237121
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1(A) Schematic representation of the of the flow-focusing microfluidic device; (B) histogram of alginate microspheres diameter; (C) FESEM image of a representative microsphere.
Figure 2(A,B) FTIR spectrum of a flat uncoated alginate hydrogel (ALG) and a three-layer layer-by-layer coating collagen-hyaluronic acid-collagen (COL-HA-COL); (C) Collagen content in the layer-by-layer coating by adding layers of collagen and hyaluronic acid successively, as determined by Micro-BCA. ALG: alginate hydrogel; COL: collagen; HA: hyaluronic acid.
Figure 3Graphic representation of the different forms of cultivation performed: (A) conventional 2D culture; (B) suspension culture (SUP condition); (C) suspension culture incorporating non-functionalized alginate microspheres (UCM condition); and (D) representation of suspension culture in an environment with components of the extracellular matrix incorporating 50% of alginate microspheres with the last layer of hyaluronic acid and 50% of collagen type I (MIX condition). mPC, monoclonal plasma cell; UCM, alginate microspheres; HAM, alginate microspheres with the last layer of hyaluronic acid; COLM, alginate microspheres with the last layer of collagen type I. (E) shows a picture of alginate microspheres stained with Alcian blue and suspended in the aqueous medium of the same proportion as the cell culture.
Figure 4(A) Fraction of cells in G0–G1 phases; (B) cell number in the different culture environments; (C) percentage of cell viability. The level of statistical significance is shown as: (**) p-value ≤ 0.01; (***) p-value ≤ 0.001.
Figure 5Percentage of apoptotic cells after exposition to DEX (A,B) and BRZ (C). 2D culture at varying DEX dose (A); influence of the presence of hyaluronic acid or collagen on the development of drug resistance (B,C). The level of statistical significance is shown as (***) p-value ≤ 0.001. 2D, conventional 2D control culture; SUP, suspension control; UCM, control with uncoated alginate microspheres; HAM, microspheres with a last layer of hyaluronic acid; COLM, microspheres with a last layer of collagen; MIX, mixture of 50% HAM and 50% COLM microspheres.